Global Oncolytic Viral Drugs Market Growth 2026-2032
The global Oncolytic Viral Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Oncolytic virus (OV) is a type of virus that can specifically replicate and cause cancer cell apoptosis while sparing normal tissue from being destroyed. Oncolytic virus therapy is a promising cancer treatment method. OVs can be divided into 2 main categories: natural viruses and genetically modified viruses. Naturally occurring OVs include reovirus, Newcastle disease virus (NDV), enterovirus and measles virus (MV), etc., and most OVs have been genetically modified to increase the tropism of the virus to tumor cells and improve virus selection. sexual replication and lytic potential, and enhance host anti-tumor immunity.
United States market for Oncolytic Viral Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oncolytic Viral Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oncolytic Viral Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oncolytic Viral Drugs players cover Amgen, Inc., Daiichi Sankyo Co., Ltd., Rigvir Holding, Shanghai Pharma Sunway Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oncolytic Viral Drugs Industry Forecast” looks at past sales and reviews total world Oncolytic Viral Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncolytic Viral Drugs sales for 2026 through 2032. With Oncolytic Viral Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Viral Drugs industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Viral Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncolytic Viral Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Viral Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Viral Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Viral Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Viral Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oncolytic virus (OV) is a type of virus that can specifically replicate and cause cancer cell apoptosis while sparing normal tissue from being destroyed. Oncolytic virus therapy is a promising cancer treatment method. OVs can be divided into 2 main categories: natural viruses and genetically modified viruses. Naturally occurring OVs include reovirus, Newcastle disease virus (NDV), enterovirus and measles virus (MV), etc., and most OVs have been genetically modified to increase the tropism of the virus to tumor cells and improve virus selection. sexual replication and lytic potential, and enhance host anti-tumor immunity.
United States market for Oncolytic Viral Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oncolytic Viral Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oncolytic Viral Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oncolytic Viral Drugs players cover Amgen, Inc., Daiichi Sankyo Co., Ltd., Rigvir Holding, Shanghai Pharma Sunway Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oncolytic Viral Drugs Industry Forecast” looks at past sales and reviews total world Oncolytic Viral Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncolytic Viral Drugs sales for 2026 through 2032. With Oncolytic Viral Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Viral Drugs industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Viral Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncolytic Viral Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Viral Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Viral Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Viral Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Viral Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Natural Virus
- Genetically Modified Virus
- Nasopharyngeal Cancer
- Melanoma
- Glioma
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen, Inc.
- Daiichi Sankyo Co., Ltd.
- Rigvir Holding
- Shanghai Pharma Sunway Biotech
- What is the 10-year outlook for the global Oncolytic Viral Drugs market?
- What factors are driving Oncolytic Viral Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Oncolytic Viral Drugs market opportunities vary by end market size?
- How does Oncolytic Viral Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Viral Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oncolytic Viral Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oncolytic Viral Drugs by Country/Region, 2021, 2025 & 2032
2.2 Oncolytic Viral Drugs Segment by Type
2.2.1 Natural Virus
2.2.2 Genetically Modified Virus
2.2.3 Oncolytic Viral Drugs Sales by Type
2.2.3.1 Global Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Oncolytic Viral Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Oncolytic Viral Drugs Sale Price by Type (2021-2026)
2.3 Oncolytic Viral Drugs Segment by Application
2.3.1 Nasopharyngeal Cancer
2.3.2 Melanoma
2.3.3 Glioma
2.3.4 Other
2.3.5 Oncolytic Viral Drugs Sales by Application
2.3.5.1 Global Oncolytic Viral Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Oncolytic Viral Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Oncolytic Viral Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oncolytic Viral Drugs Breakdown Data by Company
3.1.1 Global Oncolytic Viral Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Oncolytic Viral Drugs Sales Market Share by Company (2021-2026)
3.2 Global Oncolytic Viral Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Oncolytic Viral Drugs Revenue by Company (2021-2026)
3.2.2 Global Oncolytic Viral Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Oncolytic Viral Drugs Sale Price by Company
3.4 Key Manufacturers Oncolytic Viral Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncolytic Viral Drugs Product Location Distribution
3.4.2 Players Oncolytic Viral Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ONCOLYTIC VIRAL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Oncolytic Viral Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Oncolytic Viral Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oncolytic Viral Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oncolytic Viral Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Oncolytic Viral Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oncolytic Viral Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oncolytic Viral Drugs Sales Growth
4.4 APAC Oncolytic Viral Drugs Sales Growth
4.5 Europe Oncolytic Viral Drugs Sales Growth
4.6 Middle East & Africa Oncolytic Viral Drugs Sales Growth
5 AMERICAS
5.1 Americas Oncolytic Viral Drugs Sales by Country
5.1.1 Americas Oncolytic Viral Drugs Sales by Country (2021-2026)
5.1.2 Americas Oncolytic Viral Drugs Revenue by Country (2021-2026)
5.2 Americas Oncolytic Viral Drugs Sales by Type (2021-2026)
5.3 Americas Oncolytic Viral Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Viral Drugs Sales by Region
6.1.1 APAC Oncolytic Viral Drugs Sales by Region (2021-2026)
6.1.2 APAC Oncolytic Viral Drugs Revenue by Region (2021-2026)
6.2 APAC Oncolytic Viral Drugs Sales by Type (2021-2026)
6.3 APAC Oncolytic Viral Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncolytic Viral Drugs by Country
7.1.1 Europe Oncolytic Viral Drugs Sales by Country (2021-2026)
7.1.2 Europe Oncolytic Viral Drugs Revenue by Country (2021-2026)
7.2 Europe Oncolytic Viral Drugs Sales by Type (2021-2026)
7.3 Europe Oncolytic Viral Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Viral Drugs by Country
8.1.1 Middle East & Africa Oncolytic Viral Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oncolytic Viral Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Oncolytic Viral Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Oncolytic Viral Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncolytic Viral Drugs
10.3 Manufacturing Process Analysis of Oncolytic Viral Drugs
10.4 Industry Chain Structure of Oncolytic Viral Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncolytic Viral Drugs Distributors
11.3 Oncolytic Viral Drugs Customer
12 WORLD FORECAST REVIEW FOR ONCOLYTIC VIRAL DRUGS BY GEOGRAPHIC REGION
12.1 Global Oncolytic Viral Drugs Market Size Forecast by Region
12.1.1 Global Oncolytic Viral Drugs Forecast by Region (2027-2032)
12.1.2 Global Oncolytic Viral Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oncolytic Viral Drugs Forecast by Type (2027-2032)
12.7 Global Oncolytic Viral Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen, Inc.
13.1.1 Amgen, Inc. Company Information
13.1.2 Amgen, Inc. Oncolytic Viral Drugs Product Portfolios and Specifications
13.1.3 Amgen, Inc. Oncolytic Viral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen, Inc. Main Business Overview
13.1.5 Amgen, Inc. Latest Developments
13.2 Daiichi Sankyo Co., Ltd.
13.2.1 Daiichi Sankyo Co., Ltd. Company Information
13.2.2 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Daiichi Sankyo Co., Ltd. Main Business Overview
13.2.5 Daiichi Sankyo Co., Ltd. Latest Developments
13.3 Rigvir Holding
13.3.1 Rigvir Holding Company Information
13.3.2 Rigvir Holding Oncolytic Viral Drugs Product Portfolios and Specifications
13.3.3 Rigvir Holding Oncolytic Viral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Rigvir Holding Main Business Overview
13.3.5 Rigvir Holding Latest Developments
13.4 Shanghai Pharma Sunway Biotech
13.4.1 Shanghai Pharma Sunway Biotech Company Information
13.4.2 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product Portfolios and Specifications
13.4.3 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Pharma Sunway Biotech Main Business Overview
13.4.5 Shanghai Pharma Sunway Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Viral Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oncolytic Viral Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oncolytic Viral Drugs by Country/Region, 2021, 2025 & 2032
2.2 Oncolytic Viral Drugs Segment by Type
2.2.1 Natural Virus
2.2.2 Genetically Modified Virus
2.2.3 Oncolytic Viral Drugs Sales by Type
2.2.3.1 Global Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Oncolytic Viral Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Oncolytic Viral Drugs Sale Price by Type (2021-2026)
2.3 Oncolytic Viral Drugs Segment by Application
2.3.1 Nasopharyngeal Cancer
2.3.2 Melanoma
2.3.3 Glioma
2.3.4 Other
2.3.5 Oncolytic Viral Drugs Sales by Application
2.3.5.1 Global Oncolytic Viral Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Oncolytic Viral Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Oncolytic Viral Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oncolytic Viral Drugs Breakdown Data by Company
3.1.1 Global Oncolytic Viral Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Oncolytic Viral Drugs Sales Market Share by Company (2021-2026)
3.2 Global Oncolytic Viral Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Oncolytic Viral Drugs Revenue by Company (2021-2026)
3.2.2 Global Oncolytic Viral Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Oncolytic Viral Drugs Sale Price by Company
3.4 Key Manufacturers Oncolytic Viral Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncolytic Viral Drugs Product Location Distribution
3.4.2 Players Oncolytic Viral Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ONCOLYTIC VIRAL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Oncolytic Viral Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Oncolytic Viral Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oncolytic Viral Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oncolytic Viral Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Oncolytic Viral Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oncolytic Viral Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oncolytic Viral Drugs Sales Growth
4.4 APAC Oncolytic Viral Drugs Sales Growth
4.5 Europe Oncolytic Viral Drugs Sales Growth
4.6 Middle East & Africa Oncolytic Viral Drugs Sales Growth
5 AMERICAS
5.1 Americas Oncolytic Viral Drugs Sales by Country
5.1.1 Americas Oncolytic Viral Drugs Sales by Country (2021-2026)
5.1.2 Americas Oncolytic Viral Drugs Revenue by Country (2021-2026)
5.2 Americas Oncolytic Viral Drugs Sales by Type (2021-2026)
5.3 Americas Oncolytic Viral Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Viral Drugs Sales by Region
6.1.1 APAC Oncolytic Viral Drugs Sales by Region (2021-2026)
6.1.2 APAC Oncolytic Viral Drugs Revenue by Region (2021-2026)
6.2 APAC Oncolytic Viral Drugs Sales by Type (2021-2026)
6.3 APAC Oncolytic Viral Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncolytic Viral Drugs by Country
7.1.1 Europe Oncolytic Viral Drugs Sales by Country (2021-2026)
7.1.2 Europe Oncolytic Viral Drugs Revenue by Country (2021-2026)
7.2 Europe Oncolytic Viral Drugs Sales by Type (2021-2026)
7.3 Europe Oncolytic Viral Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Viral Drugs by Country
8.1.1 Middle East & Africa Oncolytic Viral Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oncolytic Viral Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Oncolytic Viral Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Oncolytic Viral Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncolytic Viral Drugs
10.3 Manufacturing Process Analysis of Oncolytic Viral Drugs
10.4 Industry Chain Structure of Oncolytic Viral Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncolytic Viral Drugs Distributors
11.3 Oncolytic Viral Drugs Customer
12 WORLD FORECAST REVIEW FOR ONCOLYTIC VIRAL DRUGS BY GEOGRAPHIC REGION
12.1 Global Oncolytic Viral Drugs Market Size Forecast by Region
12.1.1 Global Oncolytic Viral Drugs Forecast by Region (2027-2032)
12.1.2 Global Oncolytic Viral Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oncolytic Viral Drugs Forecast by Type (2027-2032)
12.7 Global Oncolytic Viral Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen, Inc.
13.1.1 Amgen, Inc. Company Information
13.1.2 Amgen, Inc. Oncolytic Viral Drugs Product Portfolios and Specifications
13.1.3 Amgen, Inc. Oncolytic Viral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen, Inc. Main Business Overview
13.1.5 Amgen, Inc. Latest Developments
13.2 Daiichi Sankyo Co., Ltd.
13.2.1 Daiichi Sankyo Co., Ltd. Company Information
13.2.2 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Daiichi Sankyo Co., Ltd. Main Business Overview
13.2.5 Daiichi Sankyo Co., Ltd. Latest Developments
13.3 Rigvir Holding
13.3.1 Rigvir Holding Company Information
13.3.2 Rigvir Holding Oncolytic Viral Drugs Product Portfolios and Specifications
13.3.3 Rigvir Holding Oncolytic Viral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Rigvir Holding Main Business Overview
13.3.5 Rigvir Holding Latest Developments
13.4 Shanghai Pharma Sunway Biotech
13.4.1 Shanghai Pharma Sunway Biotech Company Information
13.4.2 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product Portfolios and Specifications
13.4.3 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Pharma Sunway Biotech Main Business Overview
13.4.5 Shanghai Pharma Sunway Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncolytic Viral Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oncolytic Viral Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Natural Virus
Table 4. Major Players of Genetically Modified Virus
Table 5. Global Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Oncolytic Viral Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Oncolytic Viral Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Oncolytic Viral Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Oncolytic Viral Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Oncolytic Viral Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Oncolytic Viral Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Oncolytic Viral Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Oncolytic Viral Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Oncolytic Viral Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Oncolytic Viral Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Oncolytic Viral Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Oncolytic Viral Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Oncolytic Viral Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Oncolytic Viral Drugs Producing Area Distribution and Sales Area
Table 21. Players Oncolytic Viral Drugs Products Offered
Table 22. Oncolytic Viral Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oncolytic Viral Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Oncolytic Viral Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Oncolytic Viral Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Oncolytic Viral Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Oncolytic Viral Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Oncolytic Viral Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Oncolytic Viral Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Oncolytic Viral Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Oncolytic Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Oncolytic Viral Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Oncolytic Viral Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Oncolytic Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Oncolytic Viral Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Oncolytic Viral Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Oncolytic Viral Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Oncolytic Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Oncolytic Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Oncolytic Viral Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Oncolytic Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Oncolytic Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Oncolytic Viral Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Oncolytic Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Oncolytic Viral Drugs
Table 52. Key Market Challenges & Risks of Oncolytic Viral Drugs
Table 53. Key Industry Trends of Oncolytic Viral Drugs
Table 54. Oncolytic Viral Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oncolytic Viral Drugs Distributors List
Table 57. Oncolytic Viral Drugs Customer List
Table 58. Global Oncolytic Viral Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Oncolytic Viral Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Oncolytic Viral Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Oncolytic Viral Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Oncolytic Viral Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Oncolytic Viral Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Oncolytic Viral Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Oncolytic Viral Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Oncolytic Viral Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Oncolytic Viral Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Oncolytic Viral Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Oncolytic Viral Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Oncolytic Viral Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Oncolytic Viral Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Amgen, Inc. Basic Information, Oncolytic Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen, Inc. Oncolytic Viral Drugs Product Portfolios and Specifications
Table 74. Amgen, Inc. Oncolytic Viral Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Amgen, Inc. Main Business
Table 76. Amgen, Inc. Latest Developments
Table 77. Daiichi Sankyo Co., Ltd. Basic Information, Oncolytic Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product Portfolios and Specifications
Table 79. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Daiichi Sankyo Co., Ltd. Main Business
Table 81. Daiichi Sankyo Co., Ltd. Latest Developments
Table 82. Rigvir Holding Basic Information, Oncolytic Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Rigvir Holding Oncolytic Viral Drugs Product Portfolios and Specifications
Table 84. Rigvir Holding Oncolytic Viral Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Rigvir Holding Main Business
Table 86. Rigvir Holding Latest Developments
Table 87. Shanghai Pharma Sunway Biotech Basic Information, Oncolytic Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product Portfolios and Specifications
Table 89. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Shanghai Pharma Sunway Biotech Main Business
Table 91. Shanghai Pharma Sunway Biotech Latest Developments
Table 1. Oncolytic Viral Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oncolytic Viral Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Natural Virus
Table 4. Major Players of Genetically Modified Virus
Table 5. Global Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Oncolytic Viral Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Oncolytic Viral Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Oncolytic Viral Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Oncolytic Viral Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Oncolytic Viral Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Oncolytic Viral Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Oncolytic Viral Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Oncolytic Viral Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Oncolytic Viral Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Oncolytic Viral Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Oncolytic Viral Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Oncolytic Viral Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Oncolytic Viral Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Oncolytic Viral Drugs Producing Area Distribution and Sales Area
Table 21. Players Oncolytic Viral Drugs Products Offered
Table 22. Oncolytic Viral Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oncolytic Viral Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Oncolytic Viral Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Oncolytic Viral Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Oncolytic Viral Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Oncolytic Viral Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Oncolytic Viral Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Oncolytic Viral Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Oncolytic Viral Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Oncolytic Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Oncolytic Viral Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Oncolytic Viral Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Oncolytic Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Oncolytic Viral Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Oncolytic Viral Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Oncolytic Viral Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Oncolytic Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Oncolytic Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Oncolytic Viral Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Oncolytic Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Oncolytic Viral Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Oncolytic Viral Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Oncolytic Viral Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Oncolytic Viral Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Oncolytic Viral Drugs
Table 52. Key Market Challenges & Risks of Oncolytic Viral Drugs
Table 53. Key Industry Trends of Oncolytic Viral Drugs
Table 54. Oncolytic Viral Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oncolytic Viral Drugs Distributors List
Table 57. Oncolytic Viral Drugs Customer List
Table 58. Global Oncolytic Viral Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Oncolytic Viral Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Oncolytic Viral Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Oncolytic Viral Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Oncolytic Viral Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Oncolytic Viral Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Oncolytic Viral Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Oncolytic Viral Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Oncolytic Viral Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Oncolytic Viral Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Oncolytic Viral Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Oncolytic Viral Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Oncolytic Viral Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Oncolytic Viral Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Amgen, Inc. Basic Information, Oncolytic Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen, Inc. Oncolytic Viral Drugs Product Portfolios and Specifications
Table 74. Amgen, Inc. Oncolytic Viral Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Amgen, Inc. Main Business
Table 76. Amgen, Inc. Latest Developments
Table 77. Daiichi Sankyo Co., Ltd. Basic Information, Oncolytic Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product Portfolios and Specifications
Table 79. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Daiichi Sankyo Co., Ltd. Main Business
Table 81. Daiichi Sankyo Co., Ltd. Latest Developments
Table 82. Rigvir Holding Basic Information, Oncolytic Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Rigvir Holding Oncolytic Viral Drugs Product Portfolios and Specifications
Table 84. Rigvir Holding Oncolytic Viral Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Rigvir Holding Main Business
Table 86. Rigvir Holding Latest Developments
Table 87. Shanghai Pharma Sunway Biotech Basic Information, Oncolytic Viral Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product Portfolios and Specifications
Table 89. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Shanghai Pharma Sunway Biotech Main Business
Table 91. Shanghai Pharma Sunway Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oncolytic Viral Drugs
Figure 2. Oncolytic Viral Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncolytic Viral Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oncolytic Viral Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oncolytic Viral Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oncolytic Viral Drugs Sales Market Share by Country/Region (2025)
Figure 10. Oncolytic Viral Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Natural Virus
Figure 12. Product Picture of Genetically Modified Virus
Figure 13. Global Oncolytic Viral Drugs Sales Market Share by Type in 2026
Figure 14. Global Oncolytic Viral Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Oncolytic Viral Drugs Consumed in Nasopharyngeal Cancer
Figure 16. Global Oncolytic Viral Drugs Market: Nasopharyngeal Cancer (2021-2026) & (K Units)
Figure 17. Oncolytic Viral Drugs Consumed in Melanoma
Figure 18. Global Oncolytic Viral Drugs Market: Melanoma (2021-2026) & (K Units)
Figure 19. Oncolytic Viral Drugs Consumed in Glioma
Figure 20. Global Oncolytic Viral Drugs Market: Glioma (2021-2026) & (K Units)
Figure 21. Oncolytic Viral Drugs Consumed in Other
Figure 22. Global Oncolytic Viral Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global Oncolytic Viral Drugs Sale Market Share by Application (2025)
Figure 24. Global Oncolytic Viral Drugs Revenue Market Share by Application in 2026
Figure 25. Oncolytic Viral Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Oncolytic Viral Drugs Sales Market Share by Company in 2026
Figure 27. Oncolytic Viral Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Oncolytic Viral Drugs Revenue Market Share by Company in 2026
Figure 29. Global Oncolytic Viral Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Oncolytic Viral Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Oncolytic Viral Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Oncolytic Viral Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Oncolytic Viral Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Oncolytic Viral Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Oncolytic Viral Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Oncolytic Viral Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Oncolytic Viral Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Oncolytic Viral Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Oncolytic Viral Drugs Sales Market Share by Country in 2026
Figure 40. Americas Oncolytic Viral Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Oncolytic Viral Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Oncolytic Viral Drugs Sales Market Share by Region in 2026
Figure 48. APAC Oncolytic Viral Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Oncolytic Viral Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Oncolytic Viral Drugs Sales Market Share by Country in 2026
Figure 59. Europe Oncolytic Viral Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Oncolytic Viral Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Oncolytic Viral Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Oncolytic Viral Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Oncolytic Viral Drugs in 2026
Figure 76. Manufacturing Process Analysis of Oncolytic Viral Drugs
Figure 77. Industry Chain Structure of Oncolytic Viral Drugs
Figure 78. Channels of Distribution
Figure 79. Global Oncolytic Viral Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Oncolytic Viral Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Oncolytic Viral Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Oncolytic Viral Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Oncolytic Viral Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Oncolytic Viral Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Oncolytic Viral Drugs
Figure 2. Oncolytic Viral Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncolytic Viral Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oncolytic Viral Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oncolytic Viral Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oncolytic Viral Drugs Sales Market Share by Country/Region (2025)
Figure 10. Oncolytic Viral Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Natural Virus
Figure 12. Product Picture of Genetically Modified Virus
Figure 13. Global Oncolytic Viral Drugs Sales Market Share by Type in 2026
Figure 14. Global Oncolytic Viral Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Oncolytic Viral Drugs Consumed in Nasopharyngeal Cancer
Figure 16. Global Oncolytic Viral Drugs Market: Nasopharyngeal Cancer (2021-2026) & (K Units)
Figure 17. Oncolytic Viral Drugs Consumed in Melanoma
Figure 18. Global Oncolytic Viral Drugs Market: Melanoma (2021-2026) & (K Units)
Figure 19. Oncolytic Viral Drugs Consumed in Glioma
Figure 20. Global Oncolytic Viral Drugs Market: Glioma (2021-2026) & (K Units)
Figure 21. Oncolytic Viral Drugs Consumed in Other
Figure 22. Global Oncolytic Viral Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global Oncolytic Viral Drugs Sale Market Share by Application (2025)
Figure 24. Global Oncolytic Viral Drugs Revenue Market Share by Application in 2026
Figure 25. Oncolytic Viral Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Oncolytic Viral Drugs Sales Market Share by Company in 2026
Figure 27. Oncolytic Viral Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Oncolytic Viral Drugs Revenue Market Share by Company in 2026
Figure 29. Global Oncolytic Viral Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Oncolytic Viral Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Oncolytic Viral Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Oncolytic Viral Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Oncolytic Viral Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Oncolytic Viral Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Oncolytic Viral Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Oncolytic Viral Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Oncolytic Viral Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Oncolytic Viral Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Oncolytic Viral Drugs Sales Market Share by Country in 2026
Figure 40. Americas Oncolytic Viral Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Oncolytic Viral Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Oncolytic Viral Drugs Sales Market Share by Region in 2026
Figure 48. APAC Oncolytic Viral Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Oncolytic Viral Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Oncolytic Viral Drugs Sales Market Share by Country in 2026
Figure 59. Europe Oncolytic Viral Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Oncolytic Viral Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Oncolytic Viral Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Oncolytic Viral Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Oncolytic Viral Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Oncolytic Viral Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Oncolytic Viral Drugs in 2026
Figure 76. Manufacturing Process Analysis of Oncolytic Viral Drugs
Figure 77. Industry Chain Structure of Oncolytic Viral Drugs
Figure 78. Channels of Distribution
Figure 79. Global Oncolytic Viral Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Oncolytic Viral Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Oncolytic Viral Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Oncolytic Viral Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Oncolytic Viral Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Oncolytic Viral Drugs Revenue Market Share Forecast by Application (2027-2032)
